ZA200907685B - A method of producing fast dissolving tablets - Google Patents

A method of producing fast dissolving tablets

Info

Publication number
ZA200907685B
ZA200907685B ZA200907685A ZA200907685A ZA200907685B ZA 200907685 B ZA200907685 B ZA 200907685B ZA 200907685 A ZA200907685 A ZA 200907685A ZA 200907685 A ZA200907685 A ZA 200907685A ZA 200907685 B ZA200907685 B ZA 200907685B
Authority
ZA
South Africa
Prior art keywords
mixture
fast dissolving
fast
active component
sugar alcohol
Prior art date
Application number
ZA200907685A
Other languages
English (en)
Inventor
Zebunnissa Ramtoola
Ritesh Pabari
John Kelly
Original Assignee
Royal College Surgeons Ireland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38436760&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200907685(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Royal College Surgeons Ireland filed Critical Royal College Surgeons Ireland
Publication of ZA200907685B publication Critical patent/ZA200907685B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
ZA200907685A 2007-04-03 2009-10-30 A method of producing fast dissolving tablets ZA200907685B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07394008A EP1977734A1 (en) 2007-04-03 2007-04-03 A method of producing fast dissolving tablets

Publications (1)

Publication Number Publication Date
ZA200907685B true ZA200907685B (en) 2010-07-28

Family

ID=38436760

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200907685A ZA200907685B (en) 2007-04-03 2009-10-30 A method of producing fast dissolving tablets

Country Status (10)

Country Link
US (1) US20100074948A1 (zh)
EP (2) EP1977734A1 (zh)
JP (1) JP2010523552A (zh)
CN (1) CN101720219A (zh)
AT (1) ATE533471T1 (zh)
AU (1) AU2008234511A1 (zh)
CA (1) CA2682670A1 (zh)
IL (1) IL201304A0 (zh)
WO (1) WO2008120181A2 (zh)
ZA (1) ZA200907685B (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0817927A2 (pt) * 2007-10-01 2015-04-07 Lesvi Laboratorios Sl Comprimidos orodispersiveis
US20100190739A1 (en) * 2008-12-15 2010-07-29 Fleming And Company, Pharmaceuticals Rapidly Dissolving Vitamin Formulation and Methods of Using the Same
US20120077888A1 (en) * 2009-03-26 2012-03-29 Royal College Of Surgeons In Ireland Orodispersible tablets
WO2012162439A2 (en) * 2011-05-23 2012-11-29 Cem-102 Pharmaceuticals, Inc. Compositions comprising fusidic acid and packages therefor
US10463620B2 (en) 2014-10-16 2019-11-05 Cargill, Incorporated Process for preparing a directly compressible erythritol and uses thereof
CN106310229A (zh) * 2015-06-30 2017-01-11 深圳翰宇药业股份有限公司 一种马昔瑞林薄膜衣片及其制备方法
GB2546513B (en) * 2016-01-20 2020-09-16 Cubic Pharmaceuticals Ltd Process of preparing active pharmaceutical ingredient salts
CN105878300B (zh) * 2016-04-11 2020-04-07 浙江工业大学 一种药物速溶片的制备方法
CN108853041A (zh) * 2018-08-20 2018-11-23 益奇健康科技（上海）有限公司 一种口腔速崩片
JP2023534913A (ja) * 2020-07-24 2023-08-15 ディーエスエム アイピー アセッツ ビー．ブイ． 新規な速溶錠
CN112352857A (zh) * 2020-09-28 2021-02-12 苏州蓝浅信息科技有限公司 一种速溶茶片剂及其制备方法
CN115251221A (zh) * 2022-08-02 2022-11-01 青海大学 一种树莓咀嚼片及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4517179A (en) * 1983-04-29 1985-05-14 Pennwalt Corporation Rapid dissolving, uniform drug compositions and their preparation
US5178878A (en) * 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
DK0914818T3 (da) * 1996-06-14 2005-07-04 Kyowa Hakko Kogyo Kk Intraoralt hurtigt desintegrerbar tablet
US6024981A (en) * 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
WO2003080023A2 (en) * 2002-03-20 2003-10-02 Elan Pharma International Limited Fast dissolving dosage forms having reduced friability
US20030185884A1 (en) * 2002-04-01 2003-10-02 Singh Nikhilesh Nihala Therapeutic agent delivery compositions for buccal cavity absorption of pilocarpine
US20060083786A1 (en) * 2004-07-29 2006-04-20 Glenmark Pharmaceuticals Limited Taste masking pharmaceutical composition containing levocetirizine
US20070082048A1 (en) * 2005-06-08 2007-04-12 Ronald Warner Sleep aid formulations

Also Published As

Publication number Publication date
CN101720219A (zh) 2010-06-02
EP2142170A2 (en) 2010-01-13
IL201304A0 (en) 2010-05-31
WO2008120181A2 (en) 2008-10-09
JP2010523552A (ja) 2010-07-15
WO2008120181A4 (en) 2009-02-19
US20100074948A1 (en) 2010-03-25
EP1977734A1 (en) 2008-10-08
AU2008234511A1 (en) 2008-10-09
ATE533471T1 (de) 2011-12-15
EP2142170B1 (en) 2011-11-16
CA2682670A1 (en) 2008-10-09
WO2008120181A3 (en) 2008-11-27

Similar Documents

Publication Publication Date Title
ZA200907685B (en) A method of producing fast dissolving tablets
WO2009043844A3 (en) Orodispersible tablets
ES2525720T3 (es) Forma de dosificación robusta de disolución rápida
JP2006077018A5 (zh)
CO4990940A1 (es) Procedimiento para fabricar tabletas de dispersion por mordedura
AR040183A1 (es) Comprimidos bucodispensables y procedimiento para su obtencion
WO2006078593A3 (en) Direct compression formulation and process
WO2005105049A3 (en) Orally disintegrating tablets and methods of manufacture
JPH10504280A (ja) 迅速に分散する可食性ユニットおよび製品
RU2010128380A (ru) Способ получения кондитерского изделия
SK284645B6 (sk) Mnohočasticová tableta na báze častíc s potiahnutým aktívnym základom a zmesi nosičov
CO6551722A2 (es) Composiciones y tabletas farmacéuticas con recubrimiento o compresible y métodos de fabricación
WO2008052033A3 (en) Ibuprofen composition
WO2008079342A3 (en) Composition of and method for preparing orally disintegrating tablets
UA92077C2 (uk) Таблетка, що диспергується у роті
NZ592528A (en) Improved dissolution stability of calcium carbonate tablets
ES2665520T3 (es) Composiciones de celulosa microcristalina y fosfato cálcico útiles como excipientes farmacéuticos
US20120034302A1 (en) Particulate composition and the method of making the same
WO2008087323A3 (fr) Forme galenique pour l'administration par voie trans-muqueuse de paracetamol
CA2535340A1 (en) Fast dissolving tablet
RU2013115388A (ru) Смесь отвержденных сахарных спиртов
JP2009518321A5 (zh)
WO2003086362A3 (en) Method of stabilizing bupropion hydrochloride tablets
CO5170438A1 (es) Proceso para la preparacion de un comprimido de betahistina de liberacion controlada por granulacion en estado fundido y comprimido de liberacion controlada de betahistina obtenido mediante dicho proceso
WO2009135950A3 (en) Process for preparing a tablet containing excipients